Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2021 Mar;53(5):642-643.
doi: 10.1111/apt.16241.

Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' reply

Sara Rundquist  1 , Michael C Sachs  2 , Carl Eriksson  1   2 , Ola Olén  2   3 , Scott Montgomery  2   4 , Jonas Halfvarson  1
Affiliations
Editorial

Editorial: anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game-authors' reply

Sara Rundquist et al. Aliment Pharmacol Ther. 2021 Mar.
No abstract available

PubMed Disclaimer

Comment on

References

REFERENCES

    1. Rundquist S, Sachs MC, Eriksson C, et al. Drug survival of anti-TNF agents compared with vedolizumab as a second-line biological treatment in inflammatory bowel disease: results from nationwide Swedish registers. Aliment Pharmacol Ther. 2021;53:471-483.
    1. Roblin X, Paul S, Nancey S. Editorial:anti-TNF agents against vedolizumab as a second-line treatment? Not surprising tie game. Aliment Pharmacol Ther. 2021;53:640-641.
    1. Ludvigsson JF, Andersson M, Bengtsson J, et al. Swedish Inflammatory Bowel Disease Register (SWIBREG) - a nationwide quality register. Scand J Gastroenterol. 2019;1-13.
    1. Region Östergötland. IBD-4län. Slutrapport VästraGötalandsregionen. 2015.
    1. Torres J, Bonovas S, Doherty G, et al. ECCO guidelines on therapeutics in Crohn's disease: medical treatment. J Crohns Colitis. 2019;14:4-22.

Substances

LinkOut - more resources